| 1 |
33758505 | Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis. | 2021 |
1 |
| 2 |
33965541 | Van der Waals force-driven indomethacin-ss-paclitaxel nanodrugs for reversing multidrug resistance and enhancing NSCLC therapy. | 2021 Jun 15 |
4 |
| 3 |
34365218 | Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. | 2021 Nov |
1 |
| 4 |
31883360 | SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma. | 2020 Mar |
1 |
| 5 |
31156720 | Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer. | 2019 |
1 |
| 6 |
31867270 | Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. | 2019 |
1 |
| 7 |
31908478 | miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2. | 2019 |
1 |
| 8 |
29399166 | Association between Twist and multidrug resistance gene-associated proteins in Taxol®-resistant MCF-7 cells and a 293 cell model of Twist overexpression. | 2018 Jan |
1 |
| 9 |
30001527 | Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. | 2018 |
1 |
| 10 |
30521500 | LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1. | 2018 Dec 6 |
2 |
| 11 |
29072615 | The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells. | 2017 Oct 26 |
1 |
| 12 |
29085518 | Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance. | 2017 Oct |
1 |
| 13 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
1 |
| 14 |
25647149 | Increased chemoresistance to paclitaxel in the MCF10AT series of human breast epithelial cancer cells. | 2015 Apr |
1 |
| 15 |
26012295 | [Study of the relationship among expression of Survivin and MRP and the drug resistance in human nasopharyngeal carcinoma]. | 2015 Feb |
5 |
| 16 |
24680370 | Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2. | 2014 Jun 15 |
1 |
| 17 |
21903448 | Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma. | 2011 Dec |
1 |
| 18 |
19823672 | NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance. | 2009 Oct 12 |
1 |
| 19 |
15231674 | BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. | 2004 Jul 1 |
1 |
| 20 |
11334731 | Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. | 2001 May |
2 |
| 21 |
11809106 | [The expression of multiple drug resistance associated genes in ovarian cancer]. | 2000 Feb |
1 |
| 22 |
10405640 | Cytoskeletons and antimitotic agents developed in Japan. | 1999 Apr |
1 |
| 23 |
10565860 | Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. | 1999 Dec |
2 |
| 24 |
9738565 | Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. | 1998 Sep |
1 |
| 25 |
9496382 | Differences in docetaxel and paclitaxel activity in resistant tumor cells which express MRP: need of comparative clinical trials in resistant patients. | 1997 Dec |
1 |
| 26 |
9496387 | Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) | 1997 Dec |
2 |
| 27 |
8831715 | Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. | 1996 Oct 11 |
1 |
| 28 |
9816180 | PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. | 1996 Feb |
1 |
| 29 |
7601572 | MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance. | 1995 Jul 4 |
2 |
| 30 |
7916458 | The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. | 1994 Sep 13 |
1 |